Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1989-6-15
|
| pubmed:abstractText |
alpha-L-Iduronidase from human liver was purified by a three-step five-column procedure and by immunoaffinity chromatography with a monoclonal antibody raised against purified enzyme. Seven bands identified by staining with Coomassie Blue had molecular masses of 74, 65, 60, 49, 44, 18 and 13 kDa and were present in both preparations of the liver enzyme. However, relative to the immunopurification procedure, alpha-L-iduronidase purified by the five-column procedure was considerably enriched in the 65 kDa polypeptide band. The seven bands were identified by Western-blot analysis with two different monoclonal antibodies raised against alpha-L-iduronidase. The chromatographic behaviour of alpha-L-iduronidase on the antibody column was dependent upon the quantity of enzyme loaded. Above a particular load concentration a single peak of enzyme activity was eluted, whereas at load concentrations below the critical value alpha-L-iduronidase was eluted in two peaks of activity, designated form I (eluted first) and form II (eluted second). The following properties of the two forms of alpha-L-iduronidase were determined. (1) The two forms from liver were composed of different proportions of the same seven polypeptides. (2) When individually rechromatographed on the antibody column, each form from liver shifted to a more retarded elution position but essentially retained its chromatographic behaviour relative to the other form. (3) Forms I and II of liver alpha-L-iduronidase showed no difference in their activities towards disaccharide substrates derived from two glycosaminoglycan sources, heparan sulphate and dermatan sulphate. (4) The native molecular size of forms I and II of liver alpha-L-iduronidase was 65 kDa as determined by gel-permeation chromatography. (5) Immunoaffinity chromatography of extracts of human lung and kidney resulted in the separation of alpha-L-iduronidase into two forms, each with different proportions of the seven common polypeptide species. (6) Lung forms I and II were taken up readily into cultured skin fibroblasts taken from a patient with alpha-L-iduronidase deficiency. Liver forms I and II were not taken up to any significant extent. Lung form II gave intracellular contents of alpha-L-iduronidase that were more than double those of normal control fibroblasts, whereas lung form I gave contents approximately equal to normal control values. We propose that all seven polypeptides are derived from a single alpha-L-iduronidase gene product, and that different proportions of these polypeptides can function as a single alpha-L-iduronidase entity.(ABSTRACT TRUNCATED AT 400 WORDS)
|
| pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-3003148,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-30407,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-3435483,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-3689314,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-3689315,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-3707548,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-38945,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-4043081,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-4043083,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-410398,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-5432063,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-6237973,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-6421718,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-6421818,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-6437709,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-677447,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-6846845,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-6989821,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-7204389,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2470345-922886
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0264-6021
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
259
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
199-208
|
| pubmed:dateRevised |
2009-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:2470345-Antibodies, Monoclonal,
pubmed-meshheading:2470345-Chromatography, Affinity,
pubmed-meshheading:2470345-Chromatography, Gel,
pubmed-meshheading:2470345-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:2470345-Epitopes,
pubmed-meshheading:2470345-Glycoside Hydrolases,
pubmed-meshheading:2470345-Humans,
pubmed-meshheading:2470345-Iduronidase,
pubmed-meshheading:2470345-Liver
|
| pubmed:year |
1989
|
| pubmed:articleTitle |
Immunopurification and characterization of human alpha-L-iduronidase with the use of monoclonal antibodies.
|
| pubmed:affiliation |
Department of Chemical Pathology, Adelaide Children's Hospital, Australia.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|